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Brain microRNAs (miRNAs) change in abundance in response to Toxoplasma gondii
infection. However, their precise role in the pathogenesis of cerebral infection with
T. gondii oocyst remains unclear. We studied the abundance of miRNAs in the brain
of mice on days 11 and 33 post-infection (dpi) in order to identify miRNA pattern
specific to early (11 dpi) and late (33 dpi) T. gondii infection. Mice were challenged with
T. gondii oocysts (Type II strain) and on 11 and 33 dpi, the expression of miRNAs in
mouse brain was investigated using small RNA (sRNA) sequencing. miRNA expression
was confirmed by quantitative reverse transcription polymerase chain reaction (qRT-
PCR). Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway analysis were performed to identify the biological processes, molecular
functions, and cellular components, as well as pathways involved in infection. More than
1,500 miRNAs (1,352 known and 150 novel miRNAs) were detected in the infected and
control mice. The expression of miRNAs varied across time after infection; 3, 38, and
108 differentially expressed miRNAs (P < 0.05) were detected during acute infection,
chronic infection and chronic vs. acute infection, respectively. GO analysis showed
that chronically infected mice had more predicted targets of dysregulated miRNAs
than acutely infected mice. KEGG analysis indicated that most predicted targets were
involved in immune- or disease-related pathways. Our data indicate that T. gondii
infection alters the abundance of miRNAs in mouse brain particularly at the chronic
stage, probably to fine-tune conditions required for the establishment of a latent brain
infection.
Keywords: Toxoplasma gondii, oocysts, cerebral toxoplasmosis, deep sequencing, microRNAs differential
expression
INTRODUCTION
The intracellular protozoan parasite Toxoplasma gondii is an opportunistic pathogen, which
can virtually infect and replicate within any nucleated cells of warm-blooded animals and
humans (Jones and Dubey, 2012). T. gondii has a complex life cycle that includes asexual
propagation and the formation of tachyzoites and bradyzoites-containing cysts in the intermediate
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host (Black and Boothroyd, 2000) and sexual reproduction and
formation of oocysts in the intestinal epithelium of felids
(Tenter et al., 2000). Humans can be infected through (i)
ingesting undercooked meat containing T. gondii tissue cysts,
(ii) drinking water contaminated with sporulated oocysts, and
(iii) transplacental (vertical) transmission (Elsheikha, 2008). This
zoonotic pathogen infects approximately one-third of the world
population and can cause a variety of clinical symptoms and even
death in immuno-compromised patients (e.g., AIDS patients
and organ transplant recipients) and in fetuses of naïve women
infected during pregnancy (Dubey, 2008; Elsheikha, 2008; Zhou
et al., 2011).
Previous studies have reported a correlation between
a deregulated immunoinflammatory response and brain
dysfunction in infected humans and animals (Cannella et al.,
2014; Blanchard et al., 2015; Elsheikha and Zhu, 2016; Marra,
2018). Effective therapeutic interventions to control brain
infection are therefore desirable and will be facilitated by a
better understanding of the host immune response against the
parasite. However, knowledge about the molecular mechanisms
underlying the deregulation of immune responses observed in
oocyst-induced cerebral toxoplasmosis remains limited. Oocysts
have remarkable ability to endure in the environment (Lindsay
and Dubey, 2009; Torrey and Yolken, 2013). Infection acquired
through the consumption of water contaminated with T. gondii
oocysts has been frequently reported (Dubey, 2004; Hill et al.,
2011), and can be linked to even waterborne outbreaks (Boyer
et al., 2011).
MicroRNA (miRNA) profiling has emerged as a useful
approach to study the pathogenesis of many protozoan species,
such as Cryptosporidium, Plasmodium, and Toxoplasma (Judice
et al., 2016). Also, miRNAs have been promising biomarkers
for the diagnosis and monitoring of progression of parasitic
diseases (Hoy et al., 2014; Cai et al., 2015). miRNAs are short
(20–24 nucleotides) endogenous non-coding, single stranded,
RNA sequences that can control gene expression at the
posttranscriptional level and mediate regulatory signals between
cells in health and disease (Bartel, 2004; Triboulet et al., 2007;
Hobert, 2008; Winter et al., 2009; Zeiner et al., 2010). T. gondii
infection requires specific miRNA for efficient replication (Zeiner
et al., 2010; Cong et al., 2017) and can manipulate host signaling
pathways (Hakimi and Ménard, 2010). Infection with the parasite
tissue cysts and tachyzoites can alter miRNA expression in the
brain (Xu et al., 2013) and spleen (He et al., 2016) of the host,
Abbreviations: AIDS, acquired immune deficiency syndrome; cAMP, cyclic
adenosine monophosphate; cDNA, complementary deoxyribonucleic acid; CNS,
central nervous system; CsCl, cesium chloride; DNA, deoxyribonucleic acid;
dpi, days post-infection; FDR, false discovery rate; GO, gene ontology; IFN-
α, interferon alpha; IFN-γ, interferon gamma; KEGG, Kyoto encyclopedia
of genes and genomes; MAPK, mitogen-activated protein kinase; miRNA,
micro-ribonucleic acid; PBS, phosphate buffered saline; PCR-RFLP, polymerase
chain reaction-restriction fragment length polymorphism; qRT-PCR, quantitative
reverse transcription polymerase chain reaction; RINs, ribonucleic acid integrity
numbers; RNA, ribonucleic acid; RNA-seq, deep-sequencing analysis of small
ribonucleic acids; rRNA, ribosomal ribonucleic acid; SD, standard deviation;
snoRNA, small nucleolar ribonucleic acid; snRNA, small nuclear ribonucleic
acid; SOCS1, suppressor of cytokine signaling 1; sRNA, small ribonucleic acid;
TNF-α, tumor necrosis factor alpha; TPM, transcript per million; tRNA, transfer
ribonucleic acid.
respectively. However, miRNA expression patterns in the mouse
brain during acute and chronic stages of infection with T. gondii
oocysts is unknown.
We previously reported, using next-generation sequencing
technology, the differential expression of miRNAs in response
to T. gondii infection in mouse liver (Cong et al., 2017) and
brain (Xu et al., 2013). To our knowledge, no other study
has yet explored the possible role of miRNAs in murine
cerebral toxoplasmosis caused by oocyst infection. Expanding
our earlier observations of differential expression of specific
miRNAs between healthy and infected mice, we performed small
RNA transcriptome sequencing analysis of the mouse brain in
response to infection with T. gondii oocysts. Our data provide a
platform for the design of functional studies to map the function
of the differentially expressed miRNA identified in the brain
of mice infected with T. gondii oocysts. Our findings indicate
that specific miRNAs regulate the expression of inflammatory
cytokines in the mouse brain in response to infection.
MATERIALS AND METHODS
Ethics Approval
All animal experiments were approved by the Animal
Administration and Ethics Committee of Lanzhou Veterinary
Research Institute, Chinese Academy of Agricultural Sciences.
The animals were handled in compliance with the animal ethics
requirements of the People’s Republic of China. Every effort was
made to minimize animal suffering during the experiment.
Production and Purification of Oocysts
One, 10-week-old, specific-pathogen-free, kitten was infected
orally with 100 freshly prepared parasite cysts obtained from
brain homogenate of Kunming mice infected with T. gondii
PRU strain. This strain was used because the majority of human
toxoplasmosis cases have been associated with type II strains
(Howe and Sibley, 1995). The cat feces were examined daily
for the presence of oocysts. Once detected, T. gondii oocysts
were isolated from the feces using sucrose flotation and CsCl
gradient, as described previously (Staggs et al., 2009). To induce
sporulation, oocysts were centrifuged at 360 × g and the oocyst’s
pellet was suspended in 2% sulfuric acid and aerated on a
shaker for 7 days at ambient temperature. Sporulated oocysts
were washed twice with 0.85% saline and suspended in 2%
sulfuric acid. Finally, the number of oocysts was determined
using hemocytometer and adjusted to 100 oocysts/ml in PBS and
stored at 4◦C.
Infection of Mice
Female 7-week-old BALB/c mice were purchased from Lanzhou
University Laboratory Animal Centre (Lanzhou, Gansu Province,
China). All mice were handled according to protocols approved
by the Animal Ethics Committee of Lanzhou Veterinary Research
Institute, Chinese Academy of Agricultural Sciences. Mice were
housed in an Animal Biosafety Level 2 (ABSL-2) containment
laboratory, with temperature-controlled room (22 ± 0.5◦C)
under 12 h light/dark cycles. Mice were fed a commercial rodent
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pellet diet and had access to water ad libitum. Mice were rested
for 1 week before being infected. Twelve mice were randomly
divided into four groups (three mice/group): mice infected for
11 days, mice infected for 33 days, control mice for 11 days, and
control mice for 33 days. T. gondii infection was induced in each
mouse via oral inoculation of 100 T. gondii oocysts in 1 ml of PBS.
The uninfected (control) mice were sham-inoculated with 1 ml of
PBS only. Body weight of the mice was measured daily following
infection, and all mice were monitored daily for the development
of clinical signs characteristics of T. gondii infection, such as
ruﬄed hair, neurological manifestations and physical activity. At
11 and 33 dpi, mice were anesthetized by intraperitoneal injection
with 100 µl xylazine (20 mg/ml) and ketamine (1 mg/ml) in PBS,
brain tissues were harvested and quickly washed in PBS. All brain
samples were placed separately in sterile tubes, flash frozen in
liquid nitrogen, and stored frozen at−80◦C, until used.
Detection of T. gondii in the Brain
TIANamp Genomic DNA kit was used to extract DNA
from the brain tissues (TianGenTM, Beijing, China) and
DNA samples were stored frozen at −20◦C. The presence
of T. gondii in mouse brain was investigated using a semi-
nested PCR assay targeting T. gondii B1 gene (Cong et al.,
2016). Positive PCR amplicons were genotyped using PCR-
restriction fragment length polymorphism analysis (PCR-RFLP)
as previously described (Cong et al., 2015). Samples from mouse
brain were collected and fixed in 10% buffered formalin (pH
7.2) for a few days before dehydration through a graded series
of alcohol to xylol and embedded in paraffin wax. Sections of
5 µm thick from paraffin wax blocks were cut and stained with
hematoxylin and eosin (H & E) for histopathological analysis.
RNA Extraction
Total RNA was extracted from the brain tissue of infected
and non-infected mice at 11 and 33 dpi. Brain tissues were
homogenized in 1 ml Trizol reagent (Invitrogen, Carlsbad,
CA, United States). The concentration of RNA was determined
using Nanodrop 2000 spectrophotometer (Thermo Scientific,
United States). The extracted RNA samples were subjected to
quality control checks in order to ensure the high quality of
sRNA library construction. The purity of the RNA preparation
was assessed by calculating the ratio at 260 and 280 nm. All RNA
preparations had a ratio of absorbance (260/280 nm) > 1.8. The
assay also confirmed that the RNA samples were free of genomic
DNA contamination. The RNA integrity was assessed using the
RNA Nano 6000 Assay Kit of the Agilent Bioanalyzer 2100 system
(Agilent Technologies, Santa Clara, CA, United States). Only
RNA samples with the RNA integrity numbers (RINs) > 7 were
used for miRNA profiling analysis. The extracted RNA samples
were stored frozen at−80◦C, until analysis.
Small RNA Library Preparation and
Sequencing
About 3 µg of total RNA per sample was used as input material
to construct small RNA (sRNA) sequencing library according
to the instructions of NEBNext R© Multiplex sRNA Library Prep
Set for Illumina R© (NEB, United States). Index codes were added
to link sequences to the respective sample. Agilent Bioanalyzer
2100 system (Agilent, Santa Clara, CA, USA) was used to assess
the quality of the libraries using DNA High Sensitivity Chips.
Following the library generation, the coded samples was clustered
on a cBot Cluster Generation System using TruSeq SR Cluster
Kit v3-cBot-HS (Illumina). After cluster generation, the libraries
were sequenced on an Illumina HiSeq X Ten platform and 50 bp
single-end reads were generated.
Bioinformatics Analysis
Custom Perl and Python scripts were used to process the raw
reads, where ploy-N, with 5′ adapter contaminants, without 3′
adapter, or the insert tag, containing ploy A or T or G or C, and
low-quality reads were removed in order to obtain clean reads.
The Q20, Q30, GC content, and the error rate of the clean reads
were determined. A length range of 18∼35 nt from clean reads
(about 92% of total reads) was chosen to perform all subsequent
analyses. The small RNA tags were mapped to the published
reference Mus musculus genome sequence by Bowtie (Langmead
et al., 2009), without mismatch to analyze the expression and
distribution of sRNAs. Mapped sRNA tags were used to search for
known miRNA. miRbase 20.0 was used as reference, and software
mirdeep 2 (Friedländer et al., 2012) and srna-tools-cli were used
to identify the potential miRNA.
RepeatMasker and Rfam database were used for sRNA
mapping in order to remove non-coding RNAs (tRNA, rRNA,
snRNA, and snoRNA), protein-coding genes and repeat gene
sequences. The characteristics of hairpin structure of miRNA
precursors, miREvo (Wen et al., 2012) and mirdeep2 (Friedländer
et al., 2012) were integrated to predict novel miRNA. miRNA
counts and base bias on the first position of the identified miRNA
with certain length and on each position of all identified miRNAs
were identified by custom scripts. After sRNA annotation,
miFam.dat1 was utilized to search for known miRNA’s families,
and novel miRNA precursor was submitted to Rfam2 to look
for Rfam families, and then explore the occurrence of miRNA
families identified from the samples in other families. The
prediction of the target genes of miRNAs was performed using
miRanda (Betel et al., 2008) and PITA3. The quantification
of miRNA was evaluated by TPM (Zhou et al., 2010). The
DESeq R package (1.8.3) was used for the differential expression
analysis (Anders and Huber, 2010). FDR adjusted P-value
(Benjamini-Hochberg method for multiple corrections) of 0.05
was considered significant.
GO and KEGG Enrichment Analyses
Gene ontology enrichment analysis of the predicted target genes
of the differentially expressed miRNAs (P < 0.05) was performed
using the GOseq R package, based on a Wallenius non-
central hyper-geometric distribution (Young et al., 2010). KEGG4
pathway analysis and functional annotation of the predicted
1http://www.mirbase.org/ftp.shtml
2http://rfam.sanger.ac.uk/search/
3http://genie.weizmann.ac.il
4http://www.genome.jp/kegg/
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target genes were conducted using KOBAS 3.0 software (Mao
et al., 2005; Kanehisa et al., 2008).
Verification of miRNA Expression by
qRT-PCR
The data were validated by quantitative reverse transcription
PCR (qRT-PCR) analysis of seven of the differentially expressed
miRNAs (P < 0.05) in the brain sample to confirm gene
expression ratios obtained by sequencing. Total RNA from
infected and uninfected mouse groups was extracted using
Trizol method (Invitrogen, United States) and the quality
of RNA template was assessed using a NanoDrop 2000
spectrophotometer (Thermo Scientific, United States). RT-PCR
reactions were carried out in biological triplicate for each
RNA sample. The extracted RNA was treated with DNase
I to remove any residual genomic DNA and then reverse-
transcripted into single strand cDNA using Mir-XTM miRNA
First-Strand Synthesis Kit (Clontech, Mountain View, CA,
United States). SYBR R© Premix Ex TaqTM II (Takara, Shiga-ken,
Japan) was used to perform qRT-PCR reaction on QIAGEN’s
real-time PCR cycler (QIAGEN, Hilden, Germany). The 25 µl
qRT-PCR reaction contained 9 µl ddH2O, 12.5 µl SYBR
Advantage Premix (2X), 0.5 µl ROX Dye (50 X), 0.5 µl of
each miRNA-specific forward primer (Table 1), 0.5 µl mRQ
3′ Primer, and 2 µl cDNA. The qRT-PCRs were performed
under the following cycling conditions: initial denaturation
at 95◦C for 30 s, followed by 40 cycles of 95◦C for 5 s,
60◦C for 30 s; melt curve analysis was performed from 60
to 95◦C to confirm primer specificity by the presence of
single melting curve peak, indicating a single amplicon in each
qPCR reaction. No-template control and no-reverse transcriptase
control were included in each plate to verify the absence of
contamination. Expression of miRNAs was normalized to the
level of U6 small nuclear RNA (snRNA). qRT-PCR analysis
was performed using the delta-delta Ct method (11Ct) to
measure the relative abundances of miRNAs (Peltier and
Latham, 2008). The data were expressed as mean ± standard
deviation (SD). Statistical significance was determined by
Student’s t-test, with P-values of< 0.05 deemed to be statistically
significant.
RESULTS
Oocysts Infection in the Mouse Brain
Toxoplasma gondii infection was confirmed in the brain of
infected mice at 11 and 33 dpi by positive PCR results. PCR-
RFLP analysis of the positive amplicons of T. gondii B1 gene
revealed a restriction fragment pattern consistent with that
of T. gondii genotype II. The mouse brain of control group
and negative PCR control samples revealed negative results.
Histopathological analysis revealed the presence of T. gondii
cyst in the brain of infected mice at 33 dpi (Supplementary
Figure S1), whereas the parasite cysts were not detected in the
brain of uninfected mice or the brain of mice 11 days post
infection.
TABLE 1 | Oligonucleotides used as primers for miRNA-specific qRT-PCR
analysis.
miRNAs miRNA sequence (5′-3′)∗
mmu-miR-155-5p F CCGCGTTAATGCTAATTGTGATAGGGGT
mmu-miR-204-5p F CGTTCCCTTTGTCATCCTATGCCT
mmu-miR-146a-5p F CGCTGAGAACTGAATTCCATGGGTT
mmu-miR-142a-5p F GCGCGCATAAAGTAGAAAGCACTACT
mmu-miR-7043-3P F GCGACTGTGCCTCTCTGTTTTCAG
mmu-miR-144-3p F CCGCGCGTACAGTATAGATGATGTACT
mmu-miR-5114 F ACTGGAGACGGAAGCTGCAAG
U6 F GGAACGATACAGAGAAGATTAGC
U6 R TGGAACGCTTCACGAATTTGCG
∗mRQ 3′ primer was provided by the Mir-XTM miRNA First-Strand Synthesis and
SYBR R© qRT-PCR kit (Clontech) and was used as reverse primer in all Mir-X cDNA
qPCRs. F represents forward primer and R represents reverse primer.
miRNA Expression Patterns Associated
With Infection
miRNA libraries were successfully prepared from the brain of
the infected and uninfected (control) mice. Key characteristics
of the obtained sequencing data are summarized (Table 2).
After selecting the appropriate length of sRNA, the base number
distribution interval of clean reads in each sample was between
18∼35 nt; one of the highest proportions was 22 nt length
of sRNA. 91.9–93.7% of the reads aligned to the reference
M. musculus genome. During early and late infection, an unequal
number of known and novel miRNAs in infected and uninfected
mice was detected (Supplementary Tables S1, S2).
Differentially Expressed miRNA During
Acute and Chronic Infection
The pattern of global expression of miRNAs (P < 0.05) in
the brain of healthy mice was compared with that of acutely
and chronically infected mice. Total differentially expressed
miRNAs (P < 0.05) during acute and chronic infection
are summarized (Supplementary Table S3). More miRNAs
were differentially expressed during chronic compared to
acute stage of T. gondii infection (Figure 1). By comparing
acutely infected mice with uninfected mice, 2 miRNAs were
upregulated and one miRNA was downregulated (Table 3). When
comparing chronically infected mice with uninfected mouse,
more differentially expressed miRNAs (P < 0.05) were detected,
including 25 upregulated miRNAs and 13 downregulated
miRNAs (Supplementary Table S3).
Next, we compared the abundance of miRNA during acute
and chronic infection in order to determine the temporal changes
in the expression of miRNAs during the course of infection.
Out of the 108 differentially expressed miRNAs (P < 0.05), 59
were up-regulated and 49 were down-regulated. The differentially
expressed miRNAs (P< 0.05) in early and late T. gondii infection
are shown (Figure 2). The number of differentially expressed
miRNAs (P < 0.05) increased from 3 at 11 dpi to 38 at 33
dpi as shown in Supplementary Figure S2. These data indicate
that more altered expression of miRNAs characterize the brain
response to chronic T. gondii infection.
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TABLE 2 | Characteristics of the sRNA sequences obtained in the present study.
Mouse groups Sample code Raw reads Clean reads Bases Error rate (%) Q20 (%)a Q30 (%)b GC content (%)
Infected I 13,723,453 13,562,928 0.686G 0.01 0.9686 0.9291 48.84
Infected II 18,544,336 18,245,384 0.927G 0.01 0.977 0.9508 48.68
Infected III 14,433,684 14,190,848 0.722G 0.01 0.9689 0.9288 48.44
Control IV 10,419,259 10,237,888 0.521G 0.01 0.9729 0.942 48.61
Control V 16,971,162 16,541,211 0.849G 0.01 0.9575 0.921 48.62
Control VI 12,876,002 12,595,020 0.644G 0.01 0.9657 0.9323 49.9611
da
ys
po
st
in
fe
ct
io
n
Infected VII 10,271,598 10,143,170 0.541G 0.01 0.9648 0.9193 48.7
Infected VIII 13,822,880 13,609,247 0.691G 0.01 0.969 0.9304 48.44
Infected IX 13,012,055 12,786,416 0.651G 0.01 0.9631 0.9199 48.48
Control X 17,410,567 16,970,788 0.871G 0.01 0.9553 0.9169 48.68
Control XI 13,847,968 13,569,857 0.692G 0.01 0.9728 0.9432 48.89
Control XII 12,009,258 11,825,447 0.600G 0.01 0.9695 0.9309 49.1933
da
ys
po
st
in
fe
ct
io
n
aThe percentage of bases with a Phred value > 20.
bThe percentage of bases with a Phred value > 30.
To validate the deep sequencing results, qRT-PCR was carried
out on seven selected miRNAs showing different levels of
expression (i.e., 5 upregulated and 2 downregulated) in the brain
of mice. These included: mmu-miR-155-5p, mmu-miR-204-
5p, mmu-miR-146a-5p, mmu-miR-142a-5p, mmu-miR-7043-3P,
mmu-miR-144-3p, and mmu-miR-5114. As shown in Figure 3,
qRT-PCR results of the seven examined miRNAs were consistent
with those obtained by sequencing, confirming the correctness of
the obtained miRNA data.
Functional Annotation and KEGG
Pathway Enrichment Analysis of miRNA
Target Genes
To better understand the roles of the identified miRNAs in mouse
brain response to infection, the target genes of miRNAs were
identified using the computational prediction tools miRanda and
PITA. We performed GO and KEGG enrichment analyses to
identify the biological functions of the differentially expressed
miRNAs (P < 0.05) during acute and chronic infection.
The results revealed a total of 33 target genes of the three
miRNAs of “acute vs. uninfected,” 719 target genes of the 38
miRNAs of “chronic vs. uninfected,” and 1,911 target genes
of the 108 miRNAs of “chronic vs. acute.” We found that,
in “acute vs. uninfected” mice, two upregulated miRNAs were
successfully assigned to 14 significantly enriched GO terms,
and one downregulated miRNA was significantly enriched in
21 GO terms (corrected P ≤ 0.05). Among these significantly
enriched GO terms, we found that the upregulated miRNAs
were significantly enriched in negative regulation of calcium
ion transmembrane transporter activity, negative regulation of
calcium ion transmembrane transport, negative regulation of
ion transmembrane transporter activity, negative regulation
of calcium ion transport, and one downregulated gene was
significantly enriched in the cell part, cell, biological regulation,
and intracellular membrane-bounded organelle.
Regarding “chronic infection vs. uninfected” mice, we
detected 25 upregulated miRNAs that were successfully assigned
FIGURE 1 | Volcano plots of miRNA expression changes in the mouse brain. Differentially expressed miRNAs (P < 0.05) in (A) “acute vs uninfected,” (B) “chronic vs.
uninfected” and (C) “chronic vs. acute.” Red, green and blue dots represent upregulated, downregulated and non-regulated miRNAs, respectively. The x-axis
represents the log2 ratio of gene expression levels between mouse groups. The y-axis is adjusted p-value based on −log10.
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TABLE 3 | The top differentially expressed miRNAs (P < 0.05) in mouse brains during acute and chronic infection with Toxoplasma gondii oocysts.
Mouse groups miRNA Fold change p-value p-adjustment Expression
Acute vs. uninfected
mmu-miR-155-5p 1.3422 2.01E-06 0.001312 Up-regulated
mmu-miR-1983 0.70165 2.55E-05 0.0083223 Up-regulated
mmu-miR-204-5p −0.73525 0.0001809 0.039436 Down-regulated
Chronic vs uninfected
mmu-miR-146a-5p 3.7084 1.21E-61 9.77E-59 Up-regulated
mmu-miR-155-5p 4.0375 1.12E-43 4.54E-41 Up-regulated
mmu-miR-142a-3p 2.0541 1.00E-25 2.03E-23 Up-regulated
mmu-miR-142b 2.0541 1.00E-25 2.03E-23 Up-regulated
mmu-miR-203-3p 2.0275 1.77E-25 2.87E-23 Up-regulated
mmu-miR-21a-5p 1.9238 2.31E-23 3.11E-21 Up-regulated
mmu-miR-142a-5p 2.0311 4.23E-20 4.88E-18 Up-regulated
mmu-miR-147-3p 2.9077 3.22E-17 3.25E-15 Up-regulated
mmu-miR-5107-3p 2.9955 7.65E-13 6.86E-11 Up-regulated
mmu-miR-223-3p 1.838 8.64E-10 6.98E-08 Up-regulated
mmu-miR-219b-3p −1.1693 1.63E-06 0.0001015 Down-regulated
mmu-miR-219a-5p −1.1559 1.97E-06 0.0001137 Down-regulated
mmu-miR-32-5p −0.43524 5.90E-05 0.0026573 Down-regulated
mmu-miR-33-5p −0.89719 9.15E-05 0.0036973 Down-regulated
mmu-miR-99a-3p −0.83122 0.00034778 0.012218 Down-regulated
mmu-miR-199b-5p −0.74691 0.00037218 0.01253 Down-regulated
mmu-miR-326-3p −0.42889 0.00071845 0.020732 Down-regulated
mmu-miR-3081-3p −0.97471 0.00078346 0.021829 Down-regulated
mmu-miR-144-3p −0.63175 0.0010824 0.027398 Down-regulated
mmu-miR-136-5p −0.50052 0.0015125 0.035944 Down-regulated
Chronic vs. acute
mmu-miR-146a-5p 3.5491 3.24E-118 2.38E-115 Up-regulated
mmu-miR-142a-3p 2.6381 7.90E-56 1.93E-53 Up-regulated
mmu-miR-142b 2.6381 7.90E-56 1.93E-53 Up-regulated
mmu-miR-155-5p 3.0876 5.94E-28 7.26E-26 Up-regulated
mmu-miR-142a-5p 2.0908 1.26E-24 1.32E-22 Up-regulated
mmu-miR-423-5p 0.71476 2.92E-17 2.68E-15 Up-regulated
mmu-miR-21a-5p 1.6451 7.42E-15 6.04E-13 Up-regulated
mmu-miR-147-3p 2.5151 5.69E-14 4.17E-12 Up-regulated
mmu-miR-10a-5p 1.7159 7.83E-13 5.21E-11 Up-regulated
mmu-miR-5107-3p 2.7461 9.31E-10 4.87E-08 Up-regulated
mmu-miR-412-5p −1.4876 8.50E-46 1.56E-43 Down-regulated
mmu-miR-1983 −1.1776 5.92E-28 7.26E-26 Down-regulated
mmu-miR-379-5p −0.61196 6.21E-11 3.79E-09 Down-regulated
mmu-miR-1197-3p −1.3826 7.61E-11 4.29E-09 Down-regulated
mmu-miR-322-3p −0.71614 1.41E-07 5.74E-06 Down-regulated
mmu-miR-409-5p −0.63403 1.95E-06 6.49E-05 Down-regulated
mmu-miR-674-3p −0.6952 1.87E-06 6.49E-05 Down-regulated
mmu-miR-132-5p −0.58255 5.81E-06 0.0001639 Down-regulated
mmu-miR-127-3p −0.31406 1.48E-05 0.0003868 Down-regulated
mmu-miR-3081-3p −0.90774 1.73E-05 0.000422 Down-regulated
to 652 significantly enriched GO terms, and 13 downregulated
miRNAs that were significantly enriched in 532 GO terms
(corrected P ≤ 0.05). Among these significantly enriched GO
terms, many upregulated miRNAs were enriched in cell part,
cell, intracellular part, intracellular, and many downregulated
genes were enriched in the cell, cell part, intracellular part, and
intracellular.
In “chronic vs. acute” infection, 59 upregulated miRNAs
were assigned to 879 significantly enriched GO terms, and
49 downregulated miRNAs were enriched in 1,172 GO terms
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FIGURE 2 | Venn diagram showing the number of commonly expressed and
specifically expressed miRNAs between mouse groups. The miRNAs that are
significant and specific for in mice with acute infection vs. healthy control are
shown in the yellow circle. The light blue circle represents the miRNA markers
that discriminate chronically infected mice and control mice, while the purple
circle stands for the miRNA markers that permit a distinction of chronically vs.
acutely infected mice.
(corrected P ≤ 0.05). Among these significantly enriched GO
terms, many upregulated miRNAs were enriched in cell part,
cell, intracellular and intracellular part, and many downregulated
genes were enriched in the cell part, cell, single-organism process,
and intracellular.
Target genes of the differentially expressed miRNA were
mapped to terms in the KEGG database to identify signaling
pathways operating during acute and chronic infection. A total
of 33 target genes were enriched in 52 KEGG pathways
in “acute vs. uninfected” mice, 719 were enriched in 230
KEGG pathways in “chronic vs. uninfected,” and 911 were
enriched in 255 KEGG pathways in “chronic vs. acute”.
The top 20 highly enriched pathways in acute infection
are shown in Figure 4A. such as adrenergic signaling in
cardiomyocytes, calcium signaling pathway, and cardiac muscle
contraction. The top 20 highly enriched pathways during chronic
infection (Figure 4B), included immune-related pathways, such
as chemokine signaling pathway, Rap1 signaling pathway,
cAMP signaling pathway, MAPK signaling pathway, Fc gamma
R-mediated phagocytosis, and Hippo signaling pathway. Other
pathways associated with disease, such as pathways in cancer,
chronic myeloid leukemia, HTLV-I infection were also detected.
The top highly enriched pathways in “chronic vs. acute”
were also involved in pathways, such as cancer, endocrine
resistance and chronic myeloid leukemia (Figure 4C). These
results suggest that infection with T. gondii oocysts stimulates
the expression of gene targets at miRNA levels in the mouse
brain especially during chronic infection and that miRNAs
play key roles in mouse brain immune response to T. gondii
infection.
FIGURE 3 | Validation of the differentially expressed miRNAs using qRT-PCR. A bar graph showing the agreement in the expression levels of a panel of seven
miRNAs between qRT-PCR and the sequencing data. Columns and error bars indicate means and standard deviations of relative expression levels (n = 3),
respectively. X-axis, represents the differentially expressed miRNAs (P < 0.05). The y-axis shows the relative expression levels (log2 fold change).
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FIGURE 4 | KEGG analysis of the differentially expressed miRNAs (P < 0.05) revealed significant enrichment in immune-related pathways. The top 20 enriched
pathways of the differentially expressed miRNAs are presented for (A) “Acute vs. Uninfected,” (B) “Chronic vs. Uninfected” and (C) “Chronic vs. Acute.” The degree
of KEGG enrichment was determined by the enrichment factor, q-value, and miRNA gene target number. The sizes and colors of the spots represent the number of
predicted gene targets of the differentially expressed miRNAs (P < 0.05) and the q-value, respectively.
DISCUSSION
Successful outcome of T. gondii infection depends on the
parasite ability to subvert host immune response, and
to survive and replicate in a hostile host environment.
However, the mechanisms by which this parasite interferes
with host immunity in the brain remain poorly understood.
MicroRNAs (miRNAs) have been established as key regulators
of various biological processes with possible involvement in
the pathobiology of T. gondii infection (Hakimi and Ménard,
2010). T. gondii infection is capable of modulating host
microRNAs (miRNAs) in order to establish conditions that
work in favor of parasite growth (Xu et al., 2013; Cong et al.,
2017). In agreement with previous work, deep-sequencing
analysis of miRNAs of mouse brain at 11 and 33 dpi revealed
significant changes in the abundance of miRNAs attributed to
infection.
Our analysis revealed > 1,500 miRNAs in both infected
and uninfected mouse groups, and some of these were
differentially expressed in the infected brains compared with
control brain samples. For example, three differentially expressed
miRNAs (P < 0.05) were detected during acute infection,
whereas 38 differentially expressed miRNAs (P < 0.05)
were detected in chronic infection, indicating that miRNA
expression in mouse brain was influenced by the length
of time elapsed after infection (Pittman and Knoll, 2015).
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There were 108 differentially expressed miRNAs (P < 0.05)
between acutely and chronically infected mice. Although
miRNAs in mouse brain tissue challenged with T. gondii
type II cyst (PRU strain) at duration of infection of 14
and 21 dpi have been previously reported (Xu et al., 2013),
the present study demonstrated that the infecting stage and
the duration of infection can influence the expression of
miRNAs in mouse brain (Supplementary Table S4). Some of
the upregulated miRNAs (mmu-miR-155-5p, mmu-miR-146a-
5p, mmu-miR-142a-3p, mmu-miR-142b, mmu-miR-21a-5p) and
the down-regulated miRNAs (mmu-miR-409-5p, mmu-miR-
127-3p, mmu-miR-493-5p) (Table 3) have been reported in
previous studies (He et al., 2016; Cong et al., 2017), indicating
that T. gondii effect on host miRNAs is not strictly tissue-
specific.
The top 10 most differentially abundant miRNAs in chronic
infection, as shown in Table 3, were the most overexpressed
(3–4-fold increase) in chronic infection. The mmu-miR-155-5p
was shown to be abundantly expressed in immune cells involved
in mouse inflammatory responses, through inhibiting SOCS1 to
enhance IFN-α (Rao et al., 2014) and decrease TNF-α (Huck
et al., 2017). Also, the upregulation of mmu-miR-146a-5p is
relevant to myeloid cell proliferation, inflammation and cancer
(Boldin et al., 2011). The expression of the immunomodulatory
mmu-miR-155-5p and mmu-miR-146a-5p was shown to be
strain-specific and miR-146a ablation can affect early parasite
burden, leading to significant differences in IFN-γ production
and better survival in C57BL/6 mice (Cannella et al., 2014).
Therefore, downregulation of miR-146a in acute infection has
probably reduced parasite burden during early infection in order
to limit CNS colonization and parasite cyst burden. mmu-miR-
142a-3p, mmu-miR-142a-5p, and mmu-miR-142b, were also
over-expressed. Of note, mmu-miR-142, plays significant roles
in immune regulation (Sun et al., 2011, 2013, 2015), and in
the development of nasopharynx carcinoma, cell cycling or
IL-6 modulation in hematopoietic cell tissues, mature T cell
proliferation and endotoxin-induced mortality in inflammatory
processes; However, the roles of the miRNAs described above
except mmu-miR-155-5p and mmu-miR-146a-5p in the process
of T. gondii colonization remain to be elucidated.
KEGG pathway enrichment analysis based on the predicted
target genes revealed that dysregulated miRNAs in the brain of
infected mice was dominated by an immunological signature,
in agreement with the results obtained in T. gondii brain
infection with tissue cysts (Xu et al., 2013). We found
that 255 biological pathways, especially immune-related and
disease-related signaling pathways, were abundant among the
significantly enriched mRNAs. The dominance of the immune-
related signaling pathways indicates that T. gondii oocysts
establish brain infection by altering host immune response in
order to persist in the brain by forming a latent infection (Hunter
and Sibley, 2012).
Previous studies suggested that miRNAs do not only regulate
host cell development (Taganov et al., 2006; Kim et al., 2008),
but were also involved in cancer or infection (O’Connell
et al., 2007; Triboulet et al., 2007; Xiao and Rajewsky, 2009).
Therefore, we studied the altered pathways of the predicted
gene targets of the differentially expressed miRNAs (P < 0.05)
in acute and chronic infection. Although the dysregulated
miRNAs induced by early T. gondii infection were enriched in
both disease- and signaling-related pathways (Figure 4A), the
predicted targets of the upregulated or downregulated miRNAs
were not significantly enriched (corrected P > 0.05). During
chronic infection and “chronic vs. acute,” more disease-related
pathways were involved in various physiological systems and
molecular processes (Figures 4B,C). Interestingly, the targets of
the upregulated miRNAs were mainly involved in cancer-related
pathways (corrected P ≤ 0.05), such as pathways in cancer,
chronic myeloid leukemia, and thyroid cancer; but the targets
of downregulated miRNA were mainly enriched in signaling
pathways (corrected P ≤ 0.05), such as Fc epsilon RI signaling
pathway, cAMP signaling pathway and sphingolipid signaling
pathway. These results further substantiate the important roles
of miRNA in modulating brain response of mice challenged
with T. gondii oocysts especially during chronic stage of
infection.
CONCLUSION
The present study provides a comparative analysis of RNA
sequencing-based miRNA differential expression patterns in
mouse brain infected with T. gondii oocysts during acute
and chronic infection. We identified 1,352 known miRNAs
and 150 novel miRNAs. Three miRNAs were identified
in mouse brain during acute infection and 38 miRNAs
during chronic infection. These miRNAs are involved in the
regulation of disease-related pathways and immune signaling
pathways. Validation of seven differentially regulated miRNAs
by qRT-PCR confirmed the validity of the alteration of
their expression using RNA-seq analysis. Future studies are
needed to further examine the miRNA changes in host brain
and to investigate the functional roles of these differently
expressed miRNAs, which may contribute to the study of
regulatory signaling networks involved in the development of
cerebral toxoplasmosis and may provide targets for therapeutic
interventions.
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